Proton pump inhibitor co-therapy in patients receiving non-vitamin K antagonist oral anticoagulants: current evidence, gastrointestinal bleeding prevention, and clinical considerations - Top-Institutions - MDSpire

Proton pump inhibitor co-therapy in patients receiving non-vitamin K antagonist oral anticoagulants: current evidence, gastrointestinal bleeding prevention, and clinical considerations

  • By

  • Dong-Hyeok Kim

  • Yeji Kim

  • Moon-Hyun Kim

  • Jeongmin Kang

  • Junbeom Park

  • June 16, 2026

  • 0 min

Share

Top Institutions in Cardiology

Brief introduction explaining scope and methodology.

  • #1

    University of Ottawa
    University of Ottawa

    Ottawa, Ontario

    Key Differentiators

    • Gastroenterology

  • #2

    The Ottawa Hospital
    The Ottawa Hospital

    Ottawa, Ontario

    Key Differentiators

    • Gastroenterology

  • #3

    Ottawa Hospital Research Institute
    Ottawa Hospital Research Institute

    Ottawa, Ontario

    Key Differentiators

    • Gastroenterology

Original Source(s)

Proton pump inhibitor co-therapy in patients receiving non-vitamin K antagonist oral anticoagulants: current evidence, gastrointestinal bleeding prevention, and clinical considerations

  • by Dong-Hyeok Kim, Yeji Kim, Moon-Hyun Kim, Jeongmin Kang, Junbeom Park

  • June 16, 2026

Related Content

ACP Suggests First-Line Obesity Drugs

Semaglutide and tirzepatide had the greatest net benefit among evaluated treatments, the committee concluded.

Multimodality cardiovascular imaging in arrhythmic mitral valve prolapse: a state-of-the-art review from structural assessment to myocardial tissue characterization

Asymptomatic Three-Vessel Coronary Artery Disease Treated With Minimally Invasive CABG

For many people, cardiovascular disease develops silently. It can remain undetected for years, overshadowed by an active lifestyle and an apparent lack of symptoms.

  • by

  • June 16, 2026

  • 8 min